Literature DB >> 30072062

Epidemiology of Brain Tumors.

Jill S Barnholtz-Sloan1, Quinn T Ostrom2, David Cote3.   

Abstract

Incidence, prevalence, and survival for brain tumors varies by histologic type, age at diagnosis, sex, and race/ethnicity. Significant progress has been made in identifying potential risk factors for brain tumors, although more research is warranted. The strongest risk factors that have been identified thus far include allergies/atopic disease, ionizing radiation, and heritable genetic factors. Further analysis of large, multicenter, epidemiologic studies, as well as well annotated omic datasets (including genomic, epigenomic, transcriptomic, proteomic, or metabolomics data) can potentially lead to further understanding of the relationship between gene and environment in the process of brain tumor development.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Brain tumors; Epidemiology; Incidence; Population based; Survival

Mesh:

Year:  2018        PMID: 30072062     DOI: 10.1016/j.ncl.2018.04.001

Source DB:  PubMed          Journal:  Neurol Clin        ISSN: 0733-8619            Impact factor:   3.806


  41 in total

1.  Identification of gene co-expression modules and hub genes associated with the invasiveness of pituitary adenoma.

Authors:  Yuancheng Zhou; Xiaorui Fu; Zhicheng Zheng; Yu Ren; Zijian Zheng; Bohan Zhang; Min Yuan; Jian Duan; Meihua Li; Tao Hong; Guohui Lu; Dongwei Zhou
Journal:  Endocrine       Date:  2020-04-27       Impact factor: 3.633

Review 2.  Imaging signatures of glioblastoma molecular characteristics: A radiogenomics review.

Authors:  Anahita Fathi Kazerooni; Spyridon Bakas; Hamidreza Saligheh Rad; Christos Davatzikos
Journal:  J Magn Reson Imaging       Date:  2019-08-27       Impact factor: 4.813

3.  Alcohol intake and risk of glioma: results from three prospective cohort studies.

Authors:  David J Cote; Claudine M Samanic; Timothy R Smith; Molin Wang; Stephanie A Smith-Warner; Meir J Stampfer; Kathleen M Egan
Journal:  Eur J Epidemiol       Date:  2021-09-04       Impact factor: 12.434

4.  Crosstalk Between the Gut and Brain: Importance of the Fecal Microbiota in Patient With Brain Tumors.

Authors:  Yuping Li; Haixiao Jiang; Xiaolin Wang; Xiaoguang Liu; Yujia Huang; Zhiyao Wang; Qiang Ma; Lun Dong; Yajie Qi; Hengzhu Zhang; Guangyu Lu
Journal:  Front Cell Infect Microbiol       Date:  2022-06-17       Impact factor: 6.073

Review 5.  Cytology of Extraneural Metastases of Nonhematolymphoid Primary Central Nervous System Tumors: Six Cases with Histopathological Correlation and Literature Update.

Authors:  Joerg Schwock; Lorna Mirham; Zeina Ghorab
Journal:  Acta Cytol       Date:  2021-07-26       Impact factor: 2.319

6.  From blood to brain: blood cell-based biomimetic drug delivery systems.

Authors:  Yong-Jiang Li; Jun-Yong Wu; Jihua Liu; Xiaohan Qiu; Wenjie Xu; Tiantian Tang; Da-Xiong Xiang
Journal:  Drug Deliv       Date:  2021-06-18       Impact factor: 6.819

7.  Epidemiological distribution of primary central nervous system tumors in the Western Province of Saudi Arabia: a local registry from neuroscience-affiliated centers.

Authors:  Maher Kurdi; Nadeem Shafique Butt; Saleh Baeesa; Badrah Alghamdi; Yazid Maghrabi; Anas Bardeesi; Rothaina Saeedi; Ahmed I Lary
Journal:  Epidemiol Health       Date:  2021-05-23

8.  Influence of Epilepsy on the Quality of Life of Patients with Brain Tumors.

Authors:  Stanisław Krajewski; Magdalena Wójcik; Marek Harat; Jacek Furtak
Journal:  Int J Environ Res Public Health       Date:  2021-06-12       Impact factor: 3.390

9.  Palliative Care Consultation for Hospitalized Patients with Primary and Secondary Brain Tumors at a Single Academic Center.

Authors:  Rita C Crooms; Hung-Mo Lin; Sean Neifert; Stacie G Deiner; Jess W Brallier; Nathan E Goldstein; Jonathan S Gal; Laura P Gelfman
Journal:  J Palliat Med       Date:  2021-06-24       Impact factor: 2.947

Review 10.  Dopamine Receptors in Cancer: Are They Valid Therapeutic Targets?

Authors:  Arely Rosas-Cruz; Nohemí Salinas-Jazmín; Marco A Velasco- Velázquez
Journal:  Technol Cancer Res Treat       Date:  2021 Jan-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.